Hydration Pharmaceuticals Company LimitedASX: HPC

Extension of Rights Issue Closing Date

· Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Hydration Pharmaceuticals Company Limited has announced an extension of the closing date for its non-renounceable rights issue. The new closing date is now set for a later date, providing eligible shareholders additional time to submit their applications. All other terms and conditions of the rights issue remain unchanged. This announcement was authorized for release by the Board of Hydralyte USA.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/extension-of-rights-issue-closing-date-9

Release

743 Prospect Street La Jolla CA 92037 Company Announcement ASX: HPC DATE: 11/11/2026 Extension of Non-Renounceable Rights Issue Hydration solutions company The Hydration Pharmaceuticals Company Limited (ASX: HPC) (“Hydralyte USA” or “the Company”) refers to its non-renounceable pro rata...

Hydration Pharmaceuticals Company Limited on 6ix

In the deck

Story so far

Earlier from Hydration Pharmaceuticals

All Hydration Pharmaceuticals news releases